ABLYNX TO PRESENT AT THE 34th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Jan 07, 2016 06:05 am UTC| Business
GHENT, Belgium, Jan. 7, 2016 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that it will present at the 34th Annual J.P. Morgan Healthcare Conference on Thursday 14 January 2016 at 10:30...
BOURBON: Evolution in the General Management composition
Jan 07, 2016 06:04 am UTC| Business
PARIS, Jan. 7, 2016 (GLOBE NEWSWIRE) -- Evolution in the General Management composition of BOURBON The Board of Directors of BOURBON, having met on January 5, 2016, announces the end of the mandate of Nicolas Malgrain...
Banco Popular Dominicano selects Gemalto bio-sourced EMV bank card
Jan 07, 2016 06:00 am UTC| Business
AMSTERDAM, The Netherlands, Jan. 7, 2016 (GLOBE NEWSWIRE) -- Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, is delivering its bio-sourced Optelio EMV bank card to Banco Popular Dominicano, the...
NFL Play 60 to Ring The Nasdaq Stock Market Closing Bell
Jan 07, 2016 05:00 am UTC| Business
Representatives from the NFL will visit the Nasdaq MarketSite in Times Square as part of Nasdaqs 5th annual Fit Week. The week runs from January 4 to January 8, 2016 and includes bell ceremonies featuring companies that...
Jan 07, 2016 04:45 am UTC| Business
NEW YORK, Jan. 06, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of KLX Inc. (“KLX”)between March...
Adamas Announces Pricing of Public Offering of Common Stock
Jan 07, 2016 03:08 am UTC| Business
EMERYVILLE, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the pricing of its underwritten public offering of 2,500,000 shares of its common stock at a price to the...
Sage Therapeutics Announces Pricing of Public Offering of Common Stock
Jan 07, 2016 02:37 am UTC| Business
CAMBRIDGE, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Sage Therapeutics, Inc. (Nasdaq:SAGE), a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with...